Ischemic Stroke Clinical Trial
Official title:
Community Engagement for Early Recognition and Immediate Action in Stroke
The investigators plan to develop and adapt a community-partnered intervention using community health promoters ("Stroke Promoters") to deliver messaging regarding stroke symptom awareness and the need for calling 911 after stroke onset. The study investigators will implement this intervention in south side Chicago communities and measure the impact on symptom onset to hospital arrival times and EMS utilization using an interrupted time-series analysis.
The CEERIAS community-partnered research project has the following specific aims:
1. To examine personal, community, and cultural barriers to calling 911 after stroke onset
and adapt a culturally-tailored intervention for delivery in multi-ethnic communities
(African American, Hispanic, non-Hispanic White) surrounding a hospital on the south
side of Chicago;
2. To implement a culturally-adapted stroke awareness and action program and monitor its
penetration and adoption using the RE-AIM (Reach, Evaluate, Adoption, Implementation,
Maintenance) framework in multi-ethnic communities on the south side of Chicago; and
3. To assess change in early hospital arrival and EMS use at a intervention hospital before
and after the community intervention.
For aim 1, the investigators will explore and identify facilitators and barriers to calling
911 for stroke through focus groups conducted and involving key stakeholders including
children and adults, stroke survivors, neighborhood alderman/legislators, spiritual and
community leaders, school teachers, and stroke advocacy group members. The CEERIAS team will
test and culturally refine our core community-partnered pilot intervention for
implementation.
For aim 2, the investigators will identify and train Stroke Promoters from collaborating
community organizations on the adapted intervention techniques and messages, provide
materials for public dissemination, and evaluate and monitor adoption and implementation in
the surrounding communities.
For aim 3, the investigators will perform an interrupted time-series analysis of EMS use and
early hospital arrival among stroke patients before and after our intervention in south side
Chicago communities. The research team will also compare time trends in EMS use and early
hospital arrival for stroke with concurrent control PSCs on the north side of Chicago and
PSCs in St. Louis.
If the intervention is successful, the effect will be an increase in EMS use for stroke which
will translate into earlier treatment for stroke and reduced death and disability. The
CEERIAS results will be generalizable to other urban communities in the US and should be
salient to other health emergencies such as heart attack and cardiac arrest.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
| Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
| Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
| Recruiting |
NCT05518305 -
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
|
||
| Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
| Recruiting |
NCT03728738 -
Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke
|
Phase 3 | |
| Terminated |
NCT03396419 -
IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
|
||
| Recruiting |
NCT05065216 -
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04897334 -
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
|
N/A | |
| Not yet recruiting |
NCT06462599 -
Osteopontin Gene Polymorphism in Stroke Patients in Egypt
|
||
| Not yet recruiting |
NCT06032819 -
Differentiating Between Brain Hemorrhage and Contrast
|
||
| Not yet recruiting |
NCT06026696 -
Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
|
||
| Recruiting |
NCT02910180 -
Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
|
||
| Completed |
NCT02922452 -
A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT03554642 -
Walkbot Robotic Training for Improvement in Gait
|
Phase 3 | |
| Withdrawn |
NCT01866189 -
Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke
|
N/A | |
| Recruiting |
NCT03041753 -
Reperfusion Injury After Stroke Study
|
N/A | |
| Completed |
NCT02549846 -
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
|
Phase 4 | |
| Completed |
NCT02610803 -
Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke
|
N/A | |
| Completed |
NCT01678534 -
Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial
|
Phase 2 |